Page last updated: 2024-09-04

ezetimibe and zoledronic acid

ezetimibe has been researched along with zoledronic acid in 2 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(zoledronic acid)
Trials
(zoledronic acid)
Recent Studies (post-2010) (zoledronic acid)
2,4845631,4654,1086202,610

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)zoledronic acid (IC50)
Carbonic anhydrase 12Homo sapiens (human)0.316
Geranylgeranyl pyrophosphate synthaseHomo sapiens (human)0.318
Carbonic anhydrase 2Homo sapiens (human)0.062
72 kDa type IV collagenaseHomo sapiens (human)7
Farnesyl pyrophosphate synthaseHomo sapiens (human)0.2144
Farnesyl diphosphate synthaseEscherichia coli K-121.1
Farnesyl pyrophosphate synthase Leishmania donovani0.11
Geranylgeranyl pyrophosphate synthaseSaccharomyces cerevisiae S288C0.424
Carbonic anhydrase 9Homo sapiens (human)5.323
Carbonic anhydrase 14Homo sapiens (human)0.092

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for ezetimibe and zoledronic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for ezetimibe and zoledronic acid

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013